In several mouse models of T-cell lymphoma, Dlx5 has been shown to act as an oncogene by cooperating with activated Akt, Notch1/3, and/or Wnt to drive tumor formation. The gene discussed is DLX5; the disease is T-cell non-Hodgkin lymphoma.